摘要
目的探索血清β_2微球蛋白、乳酸脱氢酶在多发性骨髓瘤临床诊治的价值。方法在我院收治的多发性骨髓瘤患者中随机选出56例作为观察组,另选取来我院体检的50例健康人为对照组,对两组受检者的血清β_2微球蛋白、乳酸脱氢酶进行检测,对比分析检测结果。结果观察组受检对象的β_2-MG、LDH均高于对照组,P<0.05;在观察组多发性骨髓瘤的分期上,随着分期的增高,患者的β_2-MG、LDH水平越高,P<0.05。结论血清β_2微球蛋白和乳酸脱氢酶对于多发性骨髓瘤诊疗具有一定的临床价值,对于指导临床治疗效果具有参考价值。
Objective To explore the serum β2 microglobulin, LDH value in clinical diagnosis and treatment of multiple myeloma. Methods In our hospital in multiple myeloma patients randomly selected 56 patients as observation group, the other choose to our hospital check-up of 50 cases of healthy people as control group, On two groups of subjects of β2 microglobulin, serum lactate dehydrogenase, contrast analysis of test results. Results The observation group of β2-MG, LDH were higher than the control group, P〈0.05, in the observation group of multiple myeloma stage, with the increase of stage, the patient＇s β2-MG, LDH level is higher, P〈0.05. Conclusion The serum β2 microglobulin and lactate dehydrogenase has some clinical value for diagnosis and treatment of multiple myeloma, for guiding the clinical treatment as a reference value.
出处
《中国继续医学教育》
2016年第9期20-21,共2页
China Continuing Medical Education
